These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [The effectiveness and safety of sparfloxacine in combined therapy for tuberculosis].
    Author: Sokolova GB, Khaĭmenova TIa, Borisov SE, Lazareva IaV, Bogadel'nikova IV, Biron MG, Mozhokina GN, Tsibanev AA.
    Journal: Probl Tuberk Bolezn Legk; 2007; (6):40-5. PubMed ID: 17674470.
    Abstract:
    The effectiveness and safety of the difluoroquinolone sparflo (sparfloxacine) used in combined therapy for drug-sensitive and drug-resistant pulmonary tuberculosis were studied. Clinical trials were carried out in 60 patients with severe pulmonary tuberculosis. The more effective combinations of sparfo and other antituberculous drugs were determined. Data on the satisfactory tolerability of sparfo used in various combinations of first- and second-line agents are presented.
    [Abstract] [Full Text] [Related] [New Search]